Heat shock proteins as prognostic markers of cancer

Current Cancer Drug Targets

Volumn 14, Issue 8, 2014, Pages 713-726

  Kaigorodova, Evgeniya V ^a   Bogatyuk, Mariya V ^a  

^a CANCER RESEARCH INSTITUTE   (Russian Federation)

Author keywords

Cancer; Heat shock proteins; Hsp27; Hsp60; Hsp70; Hsp90; Prognostic markers

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; BERBERINE DERIVATIVE; CASPASE 3; CHAPERONIN 60; CYTOCHROME C; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HYPOXIA INDUCIBLE FACTOR 1; PACLITAXEL; QUERCETIN; VASCULOTROPIN;

ACUTE GRANULOCYTIC LEUKEMIA; AMINO TERMINAL SEQUENCE; ANGIOGENESIS; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; DNA BINDING; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; MICROVASCULATURE; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS REGULATION; CARCINOMA; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; PROGNOSIS;

APOPTOSIS; CARCINOMA; HEAT-SHOCK PROTEINS; HUMANS; NEOPLASMS; PROGNOSIS;

EID: 84919761852     PISSN: 15680096     EISSN: 18735576     Source Type: Journal    
DOI: 10.2174/1568009614666140926122846     Document Type: Article

References (168)

1. Sadikovic, B.; Al-Romaih, K.; Squire, J.A.; Zielenska, M. Cause and consequences of genetic and epigenetic alterations in human cancer. Curr. Genomics,2008, 9, 394-408.
2. Hanahan, D.; Weinberg, R. The hallmarks of cancer. Cell, 2000, 100, 57-70.
3. Ritossa, F.A. A new puffing pattern induced by temperature shock and DNP in Drosophila. Experientia, 1962, 18, 571-573.
4. Hartl, F. Molecular chaperones in cellular protein folding. Nature, 1996, 381, 571-579.
5. Ranford, J.C.; Coates, A.R.; Henderson, B. Chaperonins are cellsignalling proteins: the unfolding biology of molecular chaperones. Expert Rev. Mol. Med., 2000, 8, 1-17.
6. Saibil, H.R. Chaperone machines in action. Curr. Opin. Struct. Biol., 2008, 18, 35-42.
7. Taylor, R.P.; Benjamin, I.J. Small heat shock proteins: a new classification scheme in mammals. J. Mol. Cell. Cardiol., 2005, 38, 433-444.
8. Daugaard, M.; Rohde, M.; Jäättelä M. The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions. FEBS Letters., 2007, 581(19), 3702-3710.
9. Brocchieri, L.; Macario, С.E.; Macario, A. J. Hsp70 genes in the human genome: conservation and differentiation patterns predict a wide array of overlapping and specialized functions. BMC Evol. Biol., 2008, 8, 19.
10. Kampinga, H.H.; Hageman, J.; Vos, M.J.; Kubota, H.; Tanguay, R. M.; Bruford, E.A.; Cheetham, M.E.; Chen, B.; Hightower, L.E. Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones, 2009, 14, 105-111.
11. Flandrin, P.; Guyotat, D.; Duval, A.; Cornillon, J.; Tavernier, E.; Nadal, N.; Campos, L. Significance of heat-shock protein (HSP) 90 expression in acute myeloid leukemia cells. Cell Stress Chaperones, 2008, 13, 357-364.
12. Marcu, M.G.; Chadli, A.; Bouhouche, I.; Catelli, M.; Neckers, L.M. The heat shock protein 90 antagonist novobiocin interacts with a previously unrecognized ATP-binding domain in the carboxyl terminus of the chaperone. J. Biol. Chem., 2000, 275, 37181-37186.
13. Soti, С.; Racz, A.; Csermely, P. A nucleotide-dependent molecular switch controls ATP binding at the C-terminal domain of Hsp90. N-terminal nucleotide binding unmasks a C-terminal binding pocket. J. Biol. Chem., 2002, 277, 7066-7075.
14. Dollins, E. D. Structures of GRP94-nucleotide complexes reveal mechanistic differences between the hsp90 chaperones. Molec. Cell.,2007, 28, 41-56.
15. Pearl, L.H.; Prodromou, C.; Workman, P. The Hsp90 molecular chaperone: an open and shut case for treatment. Biochem. J., 2008, 410, 439-453.
16. Lindner, R.A.; Carver, J.A.; Ehrnsperger, M.; Buchner, J.; Esposito, G.; Behlke, J.; Lutsch, G.; Kotlyarov, A.; Gaestel, M. Mouse Hsp25, a small heat shock protein. Eur. J. Biochem., 2000, 267, 1923-1932.
17. Ingolia, T.D.; Craig, E.A. Four small Drosophila heat shock proteins are related to each other and to mammalian alphacrystallin. Proc. Natl. Acad. Sci. U.S.A., 1982, 79, 2360-2364.
18. Merck, K.B.; De Haard-Hoekman, W.A.; Oude Essink, B.B.; Bloemendal, H.; De Jong, W.W. Expression and aggregation of recombinant aA-crystallin and its two domains. Biochim. Biophys. Acta, 1992, 1130, 267-276.
19. Lambert, H.; Charette, S.J.; Bernier, A.F.; Guimond, A.; Landry, J. HSP27 multimerization mediated by phosphorylation-sensitive intermolecular interactions at the amino terminus. J. Biol. Chem.,1999, 274, 9378-9385.
20. Kim, K.K.; Kim, R.; Kim, S.H. Crystal structure of a small heat-shock protein. Nature, 1998, 394, 595-599
21. Lai, B.T.; Chin, N.W.; Stanek, A.E.; Keh, W.; Lanks, K.W. Quantitation and intracellular localization of the 85K heat shock protein by using monoclonal and polyclonal antibodies. Mol. Cell. Biol.,1984, 4, 2802-2810.
22. Brunet Simioni, M.; De Thonel, A.; Hammann, A.; Joly, A.L.; Bossis, G.; Fourmaux, E.; Bouchot, A.; Landry, J.; Piechaczyk, M.; Garrido, C. Heat shock protein 27 is involved in SUMO-2/3 modification of heat shock factor 1 and thereby modulates the transcription factor activity. Oncogene, 2009, 28, 3332-3344.
23. Pirkkala, L.; Nykanen, P.; Sistonen, L. Roles of the heat shock transcription factors in regulation of the heat shock response and beyond. FASEB J., 2001, 15, 1118-1131.
24. Borges, J.C.; Ramos, C.H. Protein folding assisted by chaperones. Protein Pept. Lett., 2005, 12, 257-261.
25. Srivastava, P.K.; Udono, H.; Blachere, N.E.; Li, Z. Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics,1994, 39, 93-98.
26. Buonaguro, L.; Petrizzo, A.; Tornesello, M.L.; Buonaguro, F.M. Translating tumor antigens into cancer vaccines. Clin. Vaccine Immunol., 2011, 18, 23-34.
27. Udono, H.; Srivastava P.K. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70. J. Immunol., 1994, 152, 5398-5403.
28. Сiocca, D.R.; Calderwood, S.K. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones, 2005, 10, 86-103.
29. Mehalingam, D.; Swords, R.; Carew, J.S.; Newrocki, S.T.; Bhalla, K.; Giles, F.J. Targeting HSP90 for cancer therapy. Br. J. Cancer, 2009, 100, 1523-1529.
30. Vogelstein, B.; Lane, D.; Levine, A.J. Surfing the p53 network. Nature, 2000, 408, 307-310.
31. Davidoff, A.M.; Iglehart, J.D.; Marks, J.R. Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. Proc. Natl. Acad. Sci. U.S.A., 1992, 89, 3439-3442.
32. Kaigorodova, E.V.; Litvinova, L.S.; Konovalova, E.V.; Klimova, M.V.; Tashireva, L.A.; Nosareva, O.L.; Novitskiy, V.V. The Inhibition of Hsp27 chaperone affects the level of p53 protein in tumor cells. Int. J. Biol., 2013, 5, 13-18.
33. Levy, A.P.; Levy, N.S.; Wegner, S.; Goldberg, M.A. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem., 1995, 270, 13333-13340.
34. Hu, J.; Discher, D.J.; Bishopric, N.H.; Webster, K.A. Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand. Biochem. Biophys. Res. Commun., 1998, 245, 894-899.
35. Melillo, G.; Musso, T.; Sica, A.; Taylor, L.S.; Cox, G.W.; Varesio, L. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J. Exp. Med., 1995, 182, 1683-1693.
36. Semenza, G.L.; Nejfelt, M.K.; Chi, S.M.; Antonarakis, S.E. Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc. Natl. Acad. Sci. U.S.A., 1991, 88, 5680-5684.
37. Ke, Q.; Costa, M. Hypoxia-inducible factor-1 (HIF-1). Mol. Pharmacol., 2006, 70, 1469-1480.
38. Tsutsumi, S.; Beebe, K.; Neckers, L. Impact of heat-shock protein 90 on cancer metastasis. Future Oncol., 2009, 5, 679-688.
39. Jorda, M.; Morales, A.; Ghorab, Z.; Fernandez, G.; Nadji, M.; Block, N. Her2 expression in prostatic cancer: a comparison with mammary carcinoma. J. Urol., 2002, 168, 1412-1414.
40. Di Fiore, P.P.; Pierce, J.H.; Kraus, M.H.; Segatto, O.; King, C.R.; Aaronson, S.A. ErbB-2 is a potent oncogene when overexpressed in NIH/3T3-cells. Science, 1987, 237, 178-182.
41. Vargas-Roig, L.M.; Gago, F.E.; Tello, O.; Aznar, J.C.; Ciocca, D. R. Heat shock expression and drug resistance in breast cancer patients treated with induction chemotherapy. Int. J. Cancer,1998, 79, 468-475.
42. Paul, C.; Manero, F.; Gonin, S.; Kretz-Remy, C.; Virot, S.; Arrigo, A.P. Hsp27 as a negative regulator of cytochrome C release. Mol. Cell. Biol., 2002, 22, 816-834.
43. Kaigorodova, E.V.; Ryazantseva, N.V.; Novitskii, V.V.; Maroshkina, A.N.; Belkina M.V. Effects of HSP27 chaperone on THP-1 tumor cell apoptosis. Bull. Exp. Biol. Med., 2012, 154, 77-79.
44. Pandey, P.; Farber, R.; Nakazawa, A.; Kumar, S.; Bharti, A.; Nalin, C.; Weichselbaum, R.; Kufe, D.; Kharbanda, S. Hsp27 functions as a negative regulator of cytochrome c-dependent activation of procaspase-3. Oncogene, 2000, 19, 1975-1981.
45. Kaigorodova, E.V.; Novitskiy, V.V.; Bogatyuk, M.V. Inhibition of Hsp27 chaperone increases apoptotic effect of etoposide in tumor cells. Int. J. Cancer Res., 2013, 47, 1144-1148.
46. Parcellier, A.; Schmitt, E.; Gurbuxani, S.; Seigneurin-Berny D.; Pance, A.; Chantôme, A.; Plenchette, S.; Khochbin, S.; Solary, E.; Garrido, C. HSP27 is a ubiquitin-binding protein involved in IkappaBalpha proteasomal degradation. Mol. Cell. Biol., 2003, 23, 5790-5802.
47. Charette, S.J.; Lavoie, J.N.; Lambert, H.; Landry, J. Inhibition of Daxx-mediated apoptosis by heat shock protein 27. Mol. Cell. Biol., 2000, 20, 7602-7612.
48. Mehlen, P.; Schule-Osthoff, K.; Arrigo A.P. Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks FAS/APO-1 and staurosporine-induced cell death. J. Biol. Chem., 1996, 271, 16510-16514.
49. Preville, X.; Salvemini, F.; Giruud, S.; Chaufour, S.; Paul, C.; Stepien, G.; Ursini, M.V.; Arrigo, A.P. Mammalian small stress proteins protect against oxidative stress through their ability to increase glucose-6-phosphate dehydrogenase activity and by maintaining optimal cellular detoxifying machinery. Exp. Cell. Res., 1999, 247, 61-78.
50. Cosentino, C.; Grieco, D.; Costanzo, V. ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair. EMBO J., 2011, 30, 546-555.
51. Malumbres, M.; Barbacid, M. To cycle or not to cycle: a critical decision in cancer. Nat. Rev. Cancer, 2001, 1, 222-231.
52. Srethapakdi, M.; Liu, F.; Tavorath, R.; Rosen, N. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest. Cancer Res., 2000, 60, 3940-3946.
53. Akalin, A.; Elmore, L.W.; Forsythe, H.L.; Amaker, B.A.; McCollum, E.D.; Nelson, P.S.; Ware, J.L.; Holt, S.E. A novel mechanism for chaperone-mediated telomerase regulation during prostate cancer progression. Cancer Res., 2001, 61, 4791-4796.
54. Chandrasekar, N.; Jasti, S.; Alfred-Yung, W.K.; Ali-Osman, F.; Dinh, D.H; Olivero, W.C.; Gujrati, M.; Kyritsis, A.P.; Nicolson, G. L.; Rao, J.S.; Mohanam, S. Modulation of endothelial cell morphogenesis in vitro by MMP-9 during glial-endothelial cell interactions. Clin. Exp. Metastasis, 2000, 18, 337-342.
55. Chantrain, C.F.; Shimada, H.; Jodele, S.; Groshen, S.; Ye, W.; Shalinsky, D.R.; Werb, Z.; Coussens, L.M.; DeClerck, Y.A. Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment. Cancer Res., 2004, 64, 1675-1686.
56. Bottaro, D.P.; Rubin, J.S.; Faletto, D.L.; Chan, A.M.; Kmiecik, T. E.; Vande Woude, G.F.; Aaronson, S.A. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science, 1991, 251, 802-804.
57. Arrigo, A.P.; Gibert, B. HspB1, HspB5 and HspB4 in human cancers: potent oncogenic role of some of their client proteins. Cancers, 2014, 6, 333-365.
58. Straume, O.; Shimamura, T.; Lampa, M.J.; Carretero, J.; Oyan, A. M.; Jia, D.; Borgman, C.L.; Soucheray, M.; Downing, S.R.; Short, S.M.; Kang, S.Y.; Wang, S.; Chen, L.; Collett, K.; Bachmann, I.; Wong, K.K.; Shapiro, G.I.; Kalland, K.H.; Folkman, J.; Watnick, R.S.; Akslen, L.A.; Naumov, G.N. Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer. Proc. Natl. Acad. Sci. U.S.A., 2012, 109, 8699-8704.
59. Wei, L.; Liu, T.T.; Wang, H.H.; Hong, H.M.; Yu, A.L.; Feng, H.P.; Chang, W.W. Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-kB. Breast Cancer Res., 2011, 13, R101.
60. Castro, G.N.; Cayado-Gutiérrez, N.; Moncalero, V.L.; Lima, P.; De Angelis, R.L.; Chavez, V.; Cuello-Carrion, F.D.; Ciocca, D. R. Hsp27 (HSPB1): a possible surrogate molecular marker for loss of heterozygosity (LOH) of chromosome 1p in oligodendrogliomas but not in astrocytomas. Cell Stress Chaperones, 2012, 17, 779-790.
61. Ferrarini, M.; Heltai, S.; Zocchi, M.R.; Rugarli, C. Unusual expression and localization of heat-shock proteins in human tumor cells. Int. J. Cancer,1992, 51, 613-619.
62. Heike, M.; Frenzel, C.; Meier, D.; Galle, P.R.; Heike, M. Expression of stress protein gp96, a tumor rejection antigen, in human colorectal cancer. Int. J. Cancer, 2000, 86, 489-493.
63. Kaigorodova, E.V.; Ryazantseva, N.V.; Novitskii, V.V.; Belkina, M.V.; Maroshkina, A.N. The role of heat shock protein 90 in the regulation of tumor cell apoptosis. Bull. Exp. Biol. Med., 2011, 150, 450-452.
64. Vos, M.J.; Zijlstra, M.P.; Carra, S.; Sibon, O.C.; Kampinga, H.H. Small heat shock proteins, protein degradation and protein aggregation diseases. Autophagy, 2011, 7, 101-103.
65. Ciocca, D.R.; Luque, E.H. Immunological evidence for the identity between the Hsp27 estrogen-regulated heat-shock protein and the P29 estrogen receptor-associated protein in breast and endometrial cancer. Breast Cancer Res. Treat., 1991, 20, 33-42.
66. Arrigo, A.P. Human small heat shock proteins: protein interactomes of homo- and hetero- oligomeric complexes: an update. FEBS Lett., 2013, 587, 1959-1969.
67. Li, M.L.; Defren, J.; Brewer, G. Hsp27 and F-Box protein-TrCP promote degradation of mRNA decay factor AUF1. Mol. Cell. Biol., 2013, 33, 2315-2326.
68. Thonel, A.; Vandekerckhove, J.; Lanneau, D.; Selvakumar, S.; Courtois, G.; Hazoume, A.; Brunet, M.; Maurel, S.; Hammann, A.; Ribeil, J.A.; Zermati, Y.; Gabet, A.S.; Boyes, J.; Solary, E.; Hermine, O.; Garrido, C. HSP27 controls GATA-1 protein level during erythroid cell differentiation. Blood, 2010, 116, 85-96.
69. Piura, B.; Rabinovich, A.; Yavelsky, V.; Wolfson, M. Heat shock proteins and malignancies of the female genital tract. Harefuah, 2002, 141, 962-972.
70. Elpek, G.O.; Karaveli, S.; Simsek, T.; Keles, N.; Aksoy, N.H. Expression of heat-shock proteins Hsp27, Hsp70 and Hsp90 in malignant epithelial tumor of the ovaries. APMIS, 2003, 111, 523-530.
71. Zhao, M.; Shen F.; Yin Y.X.; Yang Y.Y.; Xiang D.J.; Chen Q. Increased expression of heat shock protein 27 correlates with peritoneal metastasis in epithelial ovarian cancer. Reprod. Sci., 2012, 19(7), 748-753.
72. Takeno, S.; Noguchi, T.; Kikuchi, R.; Sato, T.; Uchida, Y.; Yokoyama, S. Analysis of the survival period in respectable stage IV gastric cancer. Ann. Surg. Oncol., 2001, 8, 215-221.
73. King, K.L.; Li, A.F.; Chau, G.Y.; Chi, C.W.; Wu, C.W.; Huang, C. L.; Lui, W.Y. Prognostic significance of heat shock protein-27 expression in hepatocellular carcinoma and its relation to histologic grading and survival. Cancer, 2000, 88, 2464-2470.
74. Cornford, P.A.; Dodson, A.R.; Parsons, K.F.; Desmond, A.D.; Woolfenden, A.; Fordham, M.; Neoptolemos, J.P.; Ke, Y.; Foster, C.S. Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res., 2000, 60, 7099-7105.
75. Uozaki, H.; Ishida, T.; Kakiuchi, C.; Horiuchi, H.; Gotoh, T.; Iijima, T.; Imamura, T.; Machinami, R. Expression of heat shock proteins in osteosarcoma and its relationship to prognosis. Pathol. Res. Pract., 2000, 196, 665-673.
76. Moon, A.; Bacchini, P.; Bertoni, F.; Olvi, L.G.; Santini-Araujoll, E.; Kim, Y.W.; Park Y.-K. Expression of heat shock proteins in osteosarcomas. Anatomical Pathology, 2010, 42(5), 421-425.
77. Thomas, X.; Campos, L.; Mounier, C.; Cornillon, J.; Flandrin, P.; Le, Q.H.; Piselli, S.; Guyotat, D. Expression of heat-shock proteins is associated with major adverse prognostic factors in acute myeloid leukemia. Leuk. Res., 2005, 29, 1049-1058.
78. Yu, Z.; Zhi, J.; Peng, X.; Zhong, X.; Xu, A. Clinical significance of HSP27 expression in colorectal cancer. Mol. Med. Rep., 2010, 3, 953-958.
79. Wang, F.; Zhang, P.; Shi, C.; Yang, Y.; Qin, H. Immunohistochemical detection of HSP27 and hnRNP K as prognostic and predictive biomarkers for colorectal cancer. Med Oncol., 2012, 29(3), 1780-1788.
80. Tweedle, E.M.; Khattak, I.; Ang, C.W.; Nedjadi, T.; Jenkins, R.; Park, B.K.; Kalirai, H.; Dodson, A.; Azadeh, B.; Terlizzo, M.; Grabsch, H.; Mueller, W.; Myint, S.; Clark, P.; Wong, H.; Greenhalf, W.; Neoptolemos, J.P.; Rooney, P.S.; Costello, E. Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer. Gut.,2010, 59(11), 1501-1510.
81. Wang, W.; Jia, H.L.; Huang, J.M.; Liang, Y.C.; Tan, H.; Geng, H.Z.; Guo, L.Y.; Yao, S.Z. Identification of biomarkers for lymph node metastasis in early-stage cervical cancer by tissue-based proteomics. Br. J. Cancer, 2014, 110, 1748-1758.
82. Nakajima, M.; Kuwano, H.; Miyazaki, T.; Masuda, N.; Kato, H. Significant correlation between expression of heat shock proteins 27, 70 and lymphocyte infiltration in esophageal squamous cell carcinoma. Cancer Lett., 2002, 178, 99-106.
83. Geisler, J.P.; Geisler, H.E.; Tammela, J.; Miller, G.A.; Wiemann, M.C.; Zhou, Z. A study of heat shock protein 27 in endometrial carcinoma. Gynecol. Oncol., 1999, 72, 347-350.
84. Lo Muzio, L.; Campisi, G.; Farina, A.; Rubini, C.; Ferrari, F.; Falaschini, S.; Leonardi, R.; Carinci, F.; Stalbano, S.; De Rosa, G. Prognostic value of HSP27 in head and neck squamous cell carcinoma:a retrospective analysis of 57 tumours. Anticancer Res., 2006, 26, 1343-1349.
85. Malusecka, E.; Krzyzowska-Gruca, S.; Gawrychowski, J.; Fiszer- Kierzkowska, A.; Kolosza, Z.; Krawczyk, Z. Stress proteins HSP27 and HSP70i predict survival in non-small cell lung carcinoma. Anticancer Res., 2008, 28, 501-506.
86. Marinova, D.M.; Slavova, Y.G.; Trifonova, N.; Kostadinov, D.; Maksimov, V.; Petrov, D. Stress protein Hsp27 expression predicts the outcome in operated small cell lung carcinoma and large cell neuroendocrine carcinoma patients. J. BUON., 2013, 18, 915-920.
87. Gandour-Edwards, R.; Trock, B.J.; Gumerlock, P.; Donald, P.J. Heat shock protein and p53 expression in head and neck squamous cell carcinoma. Otolaryngol. Head Neck Surg., 1998, 118, 610-615.
88. Storm, F.K.; Mahvi, D.M.; Gilchrist, K.W. Hsp27 has no diagnostic or prognostic significance in prostate or bladder cancers. Urology, 1993, 42, 379-382.
89. Erkizan, O.; Kirkali, G.; Yorukoglu, K.; Kirkali, Z. Significance of heat shock protein-27 expression in patients with renal cell carcinoma. Urology, 2004, 64, 474-478.
90. Thor, A.; Benz, C.; Moore, D.; Goldman, E.; Edgerton, S.; Landry, J.; Schwartz, L.; Mayall, B.; Hickey, E.; Weber, L.A. Stress response protein (srp-27) determination in primary human breast carcinomas: clinical, histologic, and prognostic correlations. J. Natl. Cancer Inst., 1991, 83, 170-178.
91. Storm, F.K.; Mahvi, D.M.; Gilchrist, K.W. Lack of association between tumor necrosis and hsp-27 expression in primary breast cancer. J. Surg. Oncol., 1996, 61, 14-16.
92. Thanner, F.; Sutterlin, M.W.; Kapp, M.; Rieger, L.; Morr, A.K.; Kristen, P.; Dietl, J.; Gassel, A.M.; Müller, T. Heat shock protein 27 is associated with decreased survival in node-negative breast cancer patients. Anticancer Res.,2005, 25(3A), 1649-1653.
93. Love, S.; King, R.J. A 27 kDa heat shock protein that has anomalous prognostic powers in early and advanced breast cancer. Br. J. Cancer,1994, 69, 743-748.
94. Tetu, B.; Brisson, J.; Landry, J.; Huot, J. Prognostic significance of heat-shock protein-27 in node-positive breast carcinoma: an immunohistochemical study. Breast Cancer Res. Treat., 1995, 36, 93-97.
95. Tetu, B.; Brisson, J.; Landry, J.; Huot, J. Prognostic significance of heat-shock protein-27 in node-positive breast carcinoma: an immunohistochemical study. Breast Cancer Res. Treat., 1995, 36, 93-97.
96. Oesterreich, S.; Hilsenbeck, S.G.; Ciocca, D.R.; Allred, D.C.; Clark, G.M.; Chamness, G.C.; Osborne, C.K.; Fuqua, S.A. The small heat shock protein HSP27 is not an independent prognostic marker in axillary lymph node-negative breast cancer patients. Clin. Cancer Res., 1996, 2(7), 1199-1206.
97. Soltys, B.J.; Gupta, R.S. Immunoelectron microscopic localization of the 60-kDa heat shock chaperonin protein (HSP60) in mammalian cells. Exp. Cell. Res., 1996, 222, 16-27.
98. Hansen, J.J.; Bross, P.; Westergaard, M.; Nielsen, N.M.; Eiberg, H.; Borglum, A.D.; Mogensen, J.; Kristiansen, K.; Bolund, L.; Gregersen, N. Genomic structure of the human mitochondrial chaperonin genes: HSP60 and HSP10 are localised head to head on chromosome 2 separated by a bidirectional promoter. Hum. Genet., 2003, 112, 71-77.
99. Corrao, S.; Campanella, C.; Anzalone, R.; Farina, F.; Zummo, G.; Conway de Macario, E.; Macario, A.J.; Cappello, F.; La Rocca, G. Human Hsp10 and Early Pregnancy Factor (EPF) and their relationship and involvement in cancer and immunity: Current knowledge and perspectives. Life Sci., 2010, 86(5-6), 145-152.
100. Leroux, M.R.; Hartl, F.U. Protein folding: Versatility of the cytosolic chaperonin TRiC/CCT. Curr Biol., 2000, 10(7), R260-4.
101. Soltys, B.J.; Gupta, R.S. Immunoelectron microscopic localization of the 60-kDa heat shock chaperonin protein (Hsp60) in mammalian cells. Exp. Cell Res., 1996, 222, 16-27.
102. Faried, A.; Sohda, M.; Nakajima, M.; Miyazaki, T.; Kato, H.; Kuwano, H. Expression of heat shock protein Hsp60 correlated with the apoptotic index and patient prognosis in human oesophageal squamous cell carcinoma. Eur. J. Cancer,2004, 40, 2804-2811.
103. Lebret, T.; Watson, R. W.; Molinie, V.; O'Neill, A.; Gabriel, C.; Fitzpatrick, J. M.; Botto, H. Heat shock proteins HSP27, HSP60, HSP70, and HSP90: Expression in bladder carcinoma. Cancer, 2003, 98, 970-977.
104. Xanthoudakis, S.; Roy, S.; Rasper, D.; Hennessey, T.; Aubin, Y.; Cassady, R.; Tawa, P.; Ruel, R.; Rosen, A.; Nicholson, D.W. HSP60 accelerates the maturation of pro-caspase-3 by upstream activator proteases during apoptosis. EMBO J., 1999, 18, 2049-2056.
105. Cappello, F.; David, S.; Rappa, F.; Bucchieri, F.; Marasa, L.; Bartolotta, T.E.; Farina, F.; Zummo, G. The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase. BMC Cancer, 2005, 5, 139.
106. Francesco Cappello, F.; David, S.; Rappa, F.; Bucchieri, F.; Marasà, L.; Bartolotta, T.E.; Farina, F.; Zummo, G. The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase. BMC Cancer, 2005, 5, 139.
107. Xu, X.; Wang, W.; Shao, W.; Yin, W.; Chen, H.; Qiu, Y.; Mo, M.; Zhao, J.; Deng, Q.; He, J. Heat shock protein-60 expression was significantly correlated with the prognosis of lung adenocarcinoma. J. Surg. Oncol., 2011, 104, 598-603.
108. Kirchhoff, S.R.; Gupta, S.; Knowlton, A.A. Cytosolic heat shock protein 60, apoptosis, and myocardial injury. Circulation, 2002, 105, 2899-2904.
109. Bini, L.; Magi, B.; Marzocchi, B.; Arcuri, F.; Tripodi, S.; Cintorino, M.; Sanchez, J.C.; Frutiger, S.; Hughes, G.; Pallini, V.; Hochstrasser, D.F.; Tosi, P. Protein expression profiles in human breast ductal carcinoma and histologically normal tissue. Electrophoresis, 1997, 18, 2832-2841.
110. Li, D.Q.; Wang, L.; Fei, F.; Hou, Y.F.; Luo, J.M.; Wei-Chen.; Zeng, R.; Wu, J.; Lu, J.S.; Di, G.H.; Ou, Z.L.; Xia, Q.C.; Shen, Z.Z.; Shao, Z.M. Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatographyion trap-mass spectrometry. Proteomics, 2006, 6, 3352-3368.
111. Sebastiani, V.; Botti, C.; Di Tondo, U.; Visca, P.; Pizzuti, L.; Santeusanio, G.; Alo, P.L. Tissue microarray analysis of FAS, Bcl-2, Bcl-x, ER, PgR, Hsp60, p53 and Her2-neu in breast carcinoma. Anticancer Res., 2006, 26, 2983-2987.
112. Castilla, C.; Congregado, B.; Conde, J.M.; Medina, R.; Torrubia, F.J.; Japon, M.A.; Saez, C. Immunohistochemical expression of Hsp60 correlates with tumor progression and hormone resistance in prostate cancer. Urology, 2010, 76, 10171-10176.
113. Kimura, B.E.; Enns, R.E.; Alcaraz J.E.; Arboleda, J.; Slamon, D.J.; Howell, S.B. Correlation of the survival of ovarian cancer patients with mRNA expression of the 60-kD heat-shock protein HSP-60. J. Clin. Oncol., 1993, 11, 891-898.
114. Schneider, J.; Jimenez, E.; Marenbach, K.; Romero, H.; Marx, D.; Meden, H. Immunohistochemical detection of HSP60-expression in human ovarian cancer. Correlation with survival in a series of 247 patients. Anticancer Res., 1999, 19, 2141-2146.
115. Pelham, H. Hsp70 accelerates the recovery of nucleolar morphology after heat shock. EMBO J., 1984, 3, 3095-3100.
116. Tavaria, M.; Gabriele, T.; Kola, I.; Anderson, R.L. A hitchhicker’s guide to human Hsp70 family. Cell Stress Chaperones, 1996, 1, 23-28.
117. Daugaard, M.; Rohde, M.; Jaattela, M. The heat shock protein 70 family: highly homologous proteins with overlapping and distinct functions. FEBS Lett., 2007, 581, 3702-3710.
118. Fourie, A.M.; Peterson, P.A.; Yang, Y. Characterization and regulation of the major histocompatibility complex-encoded proteins Hsp70-Hom and Hsp70-1/2. Cell Stress Chaperones, 2001, 6, 282-295.
119. Bukau, B.; Weissman, J.; Horwich, A. Molecular chaperones and protein quality control. Cell, 2006, 125, 443-451.
120. Pocaly, M.; Lagarde, V.; Etienne, G.; Ribeil, J.A.; Claverol, S.; Bonneu, M.; Moreau-Gaudry, F.; Guyonnet-Duperat, V.; Hermine, O.; Melo J.V.; Dupouy, M.; Turcq, B.; Mahon, F.X.; Pasquet, J.M. Overexpression of the heat-shock protein 70 is associated to imatinib resistance in chronic myeloid leukemia. Leukemia, 2007, 21, 93-101.
121. Thanner, F.; Sutterlin, M.W.; Kapp, M.; Rieger, L.; Kristen, P.; Dietl, J.; Gassel, A.M.; Muller, T. Heat-shock protein 70 as a prognostic marker in node-negative breast cancer. Anticancer Res., 2003, 23, 1057-1062.
122. Sun, B.; Zhang, S.; Zhang, D. Identification of metastasis-related proteins and their clinical relevance to triple-negative human breast cancer. Clin. Cancer Res., 2008, 14, 7050-7059.
123. Nanbu, K.; Konishi, I.; Mandai, M.; Kuroda, H.; Hamid, A.A.; Komatsu, T.; Mori, T. Prognostic significance of heat shock proteins HSP70 and HSP90 in endometrial carcinomas. Cancer Detect. Prev., 1998, 22, 549-555.
124. Syrigos, K.N.; Harrington, K.J.; Karayiannakis, A.J.; Sekara, E.; Chatziyianni, E.; Syrigou, E.I.; Waxman, J. Clinical significance of heat shock protein-70 expression in bladder cancer. Urology, 2003, 61, 677-680.
125. Lim, S.E.; Park, S.G.; Yoo J.-H.; Park, Y.M.; Kim, H.-J.; Jang, K.-T.; Cho J.-W.; Yoo B.C.; Jung, G.-H.; Park C.K. Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules. World J. Gastroenterol., 2005, 11(14), 2072-2079.
126. Sagol, O.; Tuna, B.; Coker, A.; Karademir, S.; Obuz, F.; Astarcioglu, H.; Kupelioglu, A.; Astarcioglu, I.; Topalak, O. Immunohistochemical detection of pS2 protein and heat shock protein-70 in pancreatic adenocarcinomas. Relationship with disease extend and patient survival. Pathol. Res. Pract., 2002, 198, 77-84.
127. Santarosa, M.; Favaro, D.; Quaia, M.; Galligioni, E. Expression of heat shock protein 72 in renal cell carcinoma: possible role and prognostic implications in cancer patients. Eur. J. Cancer, 1997, 33, 873-877.
128. Noguchi, T.; Takeno, S.; Shibata, T.; Uchida, Y.; Yokoyama, S.; Muller, W. Expression of heat shock protein 70 in grossly resected esophageal squamous cell carcinoma. Ann. Thorac. Surg., 2002, 74, 222-226.
129. Ricaniadis, N.; Kataki, A.; Agnantis, N.; Androulakis, G.; Karakousis, C.P. Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma. Eur. J. Surg. Oncol., 2001, 27, 88-93.
130. Kang, Y.L.; Jung, W.Y.; Lee, H.; Jung, W.; Lee, E.; Shin, B.K.; Kim, A.; Kim, H.K.; Kim, B.H. Prognostic significance of heat shock protein 70 expression in early gastric carcinoma. Korean J. Pathol., 2013, 47(3), 219-226.
131. Beere, H.M.; Wolf, B.B.; Cain, K.; Mosser, D.D.; Mahboubi, A.; Kuwana, T.; Tailor, P.; Morimoto, R.I.; Cohen, G.M.; Green, D.R. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat. Cell Biol., 2000, 2, 469-475.
132. Bivik, C.; Rosdahl, I.; Ollinger, K. Hsp70 protects against UVB induced apoptosis by preventing release of cathepsins and cytochrome c in human melanocytes. Carcinogenesis,2007, 28, 537-544.
133. Gross, C.; Koelch, W.; DeMaio, A.; Arispe, N.; Multhoff, G. Cell surface-bound heat shock protein 70 (Hsp70) mediates perforin-independent apoptosis by specific binding and uptake of Granzyme B. J. Biol. Chem., 2003, 278, 41173-41181.
134. Multhoff, G. Heat shock protein 70 (Hsp70): membrane location, export and immunological relevance. Methods, 2007, 43, 229-237.
135. Gehrmann, M.; Stangl, S.; Kirschner, A.; Foulds, G.A.; Sievert, W.; Dob, B.T.; Walch, A.; Pockley, A.G.; Multhoff, G. Immunotherapeutic targeting of membrane Hsp70-expressing tumors using recombinant human granzyme B. PLOS ONE, 2012, 7(7), e41341.
136. Powers, M.V.; Workman, P. Inhibitors of the heat shock response: biology and pharmacology. FEBS Lett., 2007, 581, 3758-3769.
137. Srivastava, P.K; Udono, H. Heat shock protein-peptide complexes in cancer immunotherapy. Curr. Opin. Immunol., 1994, 6, 728-732.
138. Zheng, H.C.; Takahashi, H.; Li, X.H.; Hara, T.; Masuda, S.; Guan, Y.F.; Takano, Y. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas. Hum. Pathol., 2008, 3, 1042-1049.
139. Kubota, H.; Suzuki, T.; Lu, J.; Takahashi, S.; Sugita, K.; Sekiya, S.; Suzuki, N. Increased expression of GRP94 protein is associated with decreased sensitivity to X-rays in cervical cancer cell lines. Int. J. Radiat. Biol., 2005, 81, 701-709.
140. Lin, С.Y.; Lin, T.Y.; Wang, H.M.; Huang, S.F.; Fan, K.H.; Liao, C.T.; Chen, I.H.; Lee, L.Y.; Li, Y.L.; Chen, Y.J.; Cheng, A.J.; Chang, J.T. GP96 is over-expressed in oral cavity cancer and is a poor prognostic indicator for patients receiving radiotherapy. Radiat. Oncol., 2011, 6, 136.
141. Lin, T. Y.; Chang, J.T.; Wang, H.M.; Chan, S.H.; Chiu, C.C.; Lin, C.Y.; Fan, K. H.; Liao, C.T.; Chen, I.H.; Liu, T.Z.; Li, H.F.; Cheng, A.J. Proteomics of the radioresistant phenotype in head-and-neck cancer: Gp96 as a novel prediction marker and sensitizing target for radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 2010, 78, 246-256.
142. Radanyi, C.; Le Bras, G.; Messaoudi, S.; Bouclier, C.; Peyrat, J.F.; Brion, J.D.; Marsaud, V.; Renoir, J.M.; Alami, M. Synthesis and biological activity of simplified denoviose-coumarins related to novobiocin as potent inhibitors of heat-shock protein 90 (hsp90). Bioorg. Med. Chem. Lett., 2008, 18, 2495-2498.
143. Pick, E.; Kluger, Y.; Giltnane, J.M.; Moeder, C.; Camp, R.L.; Rimm, D.L.; Kluger, H.M. High HSP90 expression is associated with decreased survival in breast cancer. 2007, 67, 2932-2937.
144. Andre, F.; Zielinsk, C.C. Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents. Ann. Oncol., 2012, 23, 46-51.
145. Reis-Filho, J.S.; Tutt, A.N. Triple negative tumours: a critical review. Histopathology,2008, 52, 108-118.
146. Biaoxue, R.; Xiling, J.; Shuanying, Y.; Wei, Z.; Xiguang, C.; Jinsui, W.; Min, Z. Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients. J. Exp. Clin. Cancer Res., 2012, 31, 70.
147. Gimenez Ortiz, A.; Montalar Salcedo, J. Heat shock proteins as targets in oncology. Clin. Transl. Oncol., 2010, 12, 166-173.
148. Giaginis, C.; Daskalopoulou, S.S.; Vgenopoulou, S.; Sfiniadakis, I.; Kouraklis, G.; Theocharis, S.E. Heat Shock Protein-27, -60 and -90 expression in gastric cancer: association with clinicopathological variables and patient survival. BMC Gastroenterol., 2009, 9, 14.
149. Wang, J.; Cui, S.; Zhang, X.; Wu, Y.; Tang, H. High expression of Heat Shock Protein 90 is associated with tumor aggressiveness and poor prognosis in patients with advanced gastric cancer. PLOS ONE, 2013, 8, e62876.
150. Cardillo, M.R.; Sale, P.; Di Silverio, F. Heat shock protein-90, IL-6 and IL-10 in bladder cancer. Anticancer Res., 2000, 20, 4579-4584.
151. Drecoll, E.; Nitsche, U.; Bauer, K.; Berezowska, S.; Slotta-Huspenina, J.; Rosenberg, R.; Langer, R. Expression analysis of heat shock protein 90 (HSP90) and Her2 in colon carcinoma. Int. J. Colorectal. Dis., 2014, 29(6), 663-671.
152. Wu, X.; Wanders, A.; Wardega, P.; Tinge, B.; Gedda, L.; Bergstrom, S.; Sooman, L.; Gullbo, J.; Bergqvist, M.; Hesselius, P.; Lennartsson, J.; Ekman, S. Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin. Br. J. Cancer, 2009, 100, 334-343.
153. Uehara, Y. Natural product origins of Hsp90 inhibitors. Curr. Cancer Drug Targets, 2003, 3, 325-330.
154. Rappa, F.; Farina, F.; Zummo, G.; David, S.; Campanella, C.; Carini, G.; Tomasello, G.; Damiani, P.; Capello, F.; Conway de Macario, E.; Macario, A.J.L. HSP-molecular chaperones in cancer biogenesis and tumor therapy: An overview. Anticancer Res.,2012, 32, 5139-5150.
155. Workman, P. Altered states: selectively drugging the Hsp90 cancer chaperone. Trends Mol. Med., 2004, 10, 47-51.
156. Trepel, J.; Mollapour, M.; Giaccone, G.; Neckers, L. Targeting the dynamic HSP90 complex in cancer. Nat. Rev. Cancer, 2010, 10, 537-549.
157. Trepel, J.; Mollapour, M.; Giaccone, G.; Neckers, L. Targeting the dynamic HSP90 complex in cancer. Nat. Rev. Cancer, 2010, 10, 537-549.
158. Powers, M.V.; Jones, K.; Barillari, C.; Westwood, I.; Montfort, R. L.; Workman, P. Targeting HSP70: the second potentially druggable heat shock protein and molecular chaperone? Cell Cycle, 2011, 9, 1542-1550.
159. Liu, X.; Yan, Z.; Huang, L.; Guo, M.; Zhang, Z.; Guo, C. Cell surface heat shock protein 90 modulates prostate cancer cell adhesion and invasion through the integrin-β1/focal adhesion kinase/c-Src sig-naling pathway. Oncol. Rep., 2011, 25, 1343-1351.
160. Campanella, C.; Bucchieri, F.; Merendino, A. M.; Fucarino, A.; Burgio, G.; Corona, D. F.; Barbieri, G.; David, S.; Farina, F.; Zummo, G.; de Macario, E. C.; Macario, A. J.; Cappello, F. The odyssey of Hsp60 from tumor cells to other destinations includes plasma membrane-associated stages and Golgi and exosomal protein-trafficking modalities. PLOS One, 2012, 7(7), e42008.
161. Morino, M.; Tsuzuki, T.; Ishikawa, Y.; Shirakami, T.; Yoshimura, M.; Kiyosuke, Y.; Matsunaga, K.; Yoshikumi, C.; Saijo, N. Specific regulation of HSPs in human tumor cell lines by flavonoids. In Vivo, 1997, 11, 265-270.
162. Tanaka, Y.; Fujiwara, K.; Tanaka, H.; Maehata, K.; Kohno, I. Paclitaxel inhibits expression of heat shock protein 27 in ovarian and uterine cancer cells. Int. J. Gynecol. Cancer, 2004, 14, 616-620.
163. Taba, K.; Kuramitsu, Y.; Ryozawa, S.; Yoshida, K.; Tanaka, T.; Mori-Iwamoto, S.; Maehara, S.; Maehara, Y.; Sakaida, I.; Nakamura, K. KNK437 downregulates heat shock protein 27 of pancreatic cancer cells and enhances the cytotoxic effect of gemcitabine. Chemotherapy, 2011, 57, 12-16.
164. Oba, M.; Yano, S.; Shuto, T.; Suico, M.A.; Eguma, A.; Kai, H. IFN-gamma down-regulates Hsp27 and enhances hyperthermia-induced tumor cell death in vitro and tumor suppression in vivo. Int. J. Oncol., 2008, 32, 1317-1324.
165. Kuramitsu, Y.; Wang, Y.; Taba, K.; Suenaga, S.; Ryozawa, S.; Kaino, S.; Sakaida, I.; Nakamura, K. Heatshock protein 27 plays the key role in gemcitabine-resistance of pancreatic cancer cells. Anticancer Res., 2012, 32, 2295-2299.
166. Shin, K.D.; Lee, M.Y.; Shin, D.S.; Lee, S.; Son, K.H.; Koh, S.; Paik, Y.K.; Kwon, B.M.; Han, D.C. Blocking tumor cell migration and invasion with biphenyl isoxazole derivative KRIBB3, a synthetic molecule that inhibits Hsp27 phosphorylation. J. Biol. Chem., 2005, 280, 41439-41448.
167. Heinrich, J.C.; Tuukkanen, A.; Schroeder, M.; Fahrig, T.; Fahrig, R. RP101 (brivudine) binds to heat shock protein HSP27 (HSPB1) and enhances survival in animals and pancreatic cancer patients. J. Cancer Res. Clin. Oncol., 2011, 137, 1349-1361.
168. Resprotect-Prevention of Chemoresistance. Available online: http://www.resprotect.de/Pipeline-Summary/Pipeline-Summary.html/ (Accessed on 16 November 2013).